GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » E10

Hybio Pharmaceutical Co (SZSE:300199) E10 : ¥-0.19 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hybio Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.19 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -104.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hybio Pharmaceutical Co was -104.10% per year. The lowest was -104.10% per year. And the median was -104.10% per year.

As of today (2025-04-07), Hybio Pharmaceutical Co's current stock price is ¥12.48. Hybio Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥-0.19. Hybio Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Hybio Pharmaceutical Co was 183.40. The lowest was 36.07. And the median was 95.34.


Hybio Pharmaceutical Co E10 Historical Data

The historical data trend for Hybio Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hybio Pharmaceutical Co E10 Chart

Hybio Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 -0.02 -0.04 -0.09 -0.17

Hybio Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.17 -0.17 -0.18 -0.19

Competitive Comparison of Hybio Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Hybio Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hybio Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hybio Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hybio Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Hybio Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hybio Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.03/115.7848*115.7848
=-0.030

Current CPI (Sep. 2024) = 115.7848.

Hybio Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.070 99.000 0.082
201503 0.042 99.900 0.049
201506 0.058 99.500 0.067
201509 0.100 100.500 0.115
201512 0.140 100.600 0.161
201603 0.066 102.200 0.075
201606 0.054 101.400 0.062
201609 0.130 102.400 0.147
201612 0.070 102.600 0.079
201703 0.085 103.200 0.095
201706 0.085 103.100 0.095
201709 0.080 104.100 0.089
201712 0.100 104.500 0.111
201803 0.107 105.300 0.118
201806 0.123 104.900 0.136
201809 0.090 106.600 0.098
201812 -0.690 106.500 -0.750
201903 0.057 107.700 0.061
201906 0.023 107.700 0.025
201909 -0.170 109.800 -0.179
201912 -0.870 111.200 -0.906
202003 0.025 112.300 0.026
202006 0.026 110.400 0.027
202009 0.010 111.700 0.010
202012 -0.720 111.500 -0.748
202103 0.030 112.662 0.031
202106 -0.060 111.769 -0.062
202109 -0.100 112.215 -0.103
202112 0.160 113.108 0.164
202203 -0.060 114.335 -0.061
202206 -0.050 114.558 -0.051
202209 -0.050 115.339 -0.050
202212 -0.260 115.116 -0.262
202303 0.020 115.116 0.020
202306 -0.060 114.558 -0.061
202309 -0.160 115.339 -0.161
202312 -0.380 114.781 -0.383
202403 -0.020 115.227 -0.020
202406 0.004 114.781 0.004
202409 -0.030 115.785 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Hybio Pharmaceutical Co  (SZSE:300199) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Hybio Pharmaceutical Co was 183.40. The lowest was 36.07. And the median was 95.34.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hybio Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hybio Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.
Executives
Ceng Shao Gui Director
Ceng Shao Bin Director
Ceng Shao Qiang Director
Zhu Wen Feng Directors, Directors, and Executives
Tao An Jin Executives
Wei Hong Executives
Yuan Jian Cheng Directors, executives
Liu Jian Executives
Yang Jun Executives
Executives
Zhu Ning Supervisors
Yang Chun Hai Supervisors
Cai Lei Directors, executives

Hybio Pharmaceutical Co Headlines

No Headlines